Polybenzoxazines obtained especially from green synthons are facing challenges of the requirement of high ring-opening polymerization (ROP) temperature of the monomer, thus affecting their exploration at the industrial front. This demands effective structural changes in the monomer itself, to mediate catalyst-free polymerization at a low energy via one-step synthesis protocol. In this regard, monomers based on disulfide-linked bisbenzoxazine were successfully synthesized using cystamine (biobased) and cardanol (agro-waste)/ phenol. Reduction of the disulfide bridge in the monomer using dithiothreitol under mild conditions in situ transformed the oxazine ring in the monomer, via neighboring group participation of the −SH group in a transient intermediate monomer, into a thiazolidine structure, which is otherwise difficult to synthesize. Structural transformation of ring-opening followed by the ring-closing intramolecular reaction led to an interconversion of O−CH 2 −N containing a six-membered oxazine ring to S−CH 2 −N containing a five-membered thiazolidine ring and a phenolic-OH. The structure of the monomer with the oxazine ring and its congener with the thiazolidine ring was characterized by spectroscopic methods and X-ray analysis. Kinetics of structural transformation at a molecular level is studied in detail, and it was found that the reaction proceeded via a transient 2-aminoethanethiol-linked benzoxazine intermediate, as supported by nuclear magnetic resonance spectroscopy and density functional theory studies. The thiazolidine-ring-containing monomer promotes ROP at a substantially low temperature than the reported mono-/bisoxazine monomers due to the dual mode of facilitation of the ROP reaction, both by phenolic-OH and by ring strain. Surprisingly, both the monomer structures led to the formation of a similar polymer structure, as supported by thermogravimetric analysis and Fourier transform infrared study. The current work highlights the benefits of inherent functionalities in naturally sourced feedstocks as biosynthons for the new latest generation of benzoxazine monomers.
Industrial applications of the upcoming class of high-performance
biobased polybenzoxazines are currently impeded by the requirement
of high polymerization temperatures. Valorization of elemental sulfur
(S8), petroleum waste, has provided attractive technological
opportunities. However, achieving sulfur copolymers at a low temperature
remains a challenging task. Here, a unique facile synthetic strategy
was adopted to form a fully sustainable solution-processable benzoxazine-sulfur
copolymer via a ring-opening polymerization reaction of isoeugenol-furfurylamine
(IE-fa, sourced from naturally abundant biobased feedstocks) and S8 at room temperature. The IE-fa benzoxazine monomer was synthesized
under neat conditions and reacted with varying percentages of S8 as sodium polysulfide (Na2S
x
) at unprecedented low temperatures (25 and 50 °C) under
catalyst-free conditions. The covalent fixation of sulfur (90 wt %),
via inverse vulcanization, within ring-opened benzoxazine resulted
in an amorphous copolymer as supported by various techniques. The
formation of S-rich and Bz-rich domains in the copolymers is governed
by the feed-in ratio of monomers and reaction temperature. Copolymers
exhibited high glass transition temperatures (10–86 °C)
due to the synergistic effects induced by H-bonded ring-opened benzoxazine
structures. The present work demonstrates the first example of benzoxazine
as a comonomer to form low-temperature solution-processable benzoxazine
sulfur benign random copolymers with mid-wave infrared transparency
and may advance benzoxazine chemistry toward transparent optics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.